Asthma treatment

One AEROBID Inhaler System is designed to deliver at least 100 metered inhalations. It is a corticosteroid that is several hundred times more potent in animal anti-inflammatory assays than the cortisol standard. Clinical studies have shown therapeutic activity on bronchial mucosa with minimal evidence of systemic activity at recommended doses. The following observations relevant to systemic absorption were made in clinical studies In one uncontrolled study a statistically significant decrease in responsiveness to metyrapone was noted in 15 adult steroid-independent patients treated with 2 A small but statistically significant drop in eosinophils from 11.

A 5% incidence of menstrual disturbances was reported during open studies, in which there were no control groups for comparison. More than 120 patients have been treated in open trials for two years or more. AEROBID inhaler is NOT indicated for the relief of acute bronchospasm. Hypersensitivity to any of the ingredients of this preparation contraindicates its use
After withdrawal from systemic corticosteroids, a number of months are required for recovery of hypothalamic-pituitary-adrenal (HPA) function. During this period of HPA suppression, patients may exhibit signs and symptoms of adrenal insufficiency when exposed to trauma, surgery or infections, particularly gastroenteritis.

To assess the risk of adrenal insufficiency in emergency situations, routine tests of adrenal cortical function, including measurement of early morning resting cortisol levels, should be performed periodically in all patients. An early morning resting cortisol level may be accepted as normal if it falls at or near the normal mean level. Localized infections with Candida albicansor, Aspergillus nigerhave occurred in the mouth and pharynx and occasionally in the larynx.

Positive cultures for oral Candidamay be present in up to 34% of patients. Although the frequency of clinically apparent infection is considerably lower, these infections may require treatment with appropriate antifungal therapy or discontinuance of treatment with AEROBID Inhaler. AEROBIDInhaler is not to be regarded as a bronchodilator and is not indicated for relief of bronchospasm. During such episodes, patients may require therapy with systemic corticosteroids. Transfer of patients from systemic steroid therapy to AEROBID Inhaler may unmask allergic conditions previously suppressed by the systemic steroid therapy. Persons who are on drugs which suppress the immune system are more susceptible to infections than healthy individuals. Chicken pox and measles, for example, can have a more serious or even fatal course in non-immune children or adults on corticosteroids. In such children or adults who have not had these diseases, particular care should be taken to avoid exposure. If exposed to chicken pox, prophylaxis with varicella zoster immune globulin (VZIG) may be indicated. If chicken pox develops, treatment with antiviral agents may be considered.

Particular care should be taken in observing patients post-operatively or during periods of stress for evidence of a decrease in adrenal function. During withdrawal from oral steroids, some patients may experience symptoms of systemically active steroid withdrawal like joint and/or muscular pain, lassitude and depression, despite maintenance or even improvement of respiratory function. In particular, the effects resulting from chronic use of AEROBID on developmental or immunologic processes in the mouth, pharynx, trachea, and lung are unknown
Inhaled corticosteroids should be used with caution, if at all, in patients with active or quiescent tuberculosis infection of the respiratory tract; untreated systemic fungal, bacterial, parasitic or viral infections; or ocular herpes simplex.

Pulmonary infiltrates with eosinophilia may occur in patients on AEROBID Inhaler therapy. Although it is possible that in some patients this state may become manifest because of systemic steroid withdrawal when inhalational steroids are administered, a causative role for the drug and/or its vehicle cannot be ruled out. Information for Patients:Since the relief from AEROBID Inhaler depends on its regular use and on proper inhalation technique, patients must be instructed to take inhalations at regular intervals.

They should also be instructed in the correct method of use. Persons who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chicken pox or measles

www.healasthma.com

Beclomethasone is a type of steroid used for respiratory problems. Beconase and Vancenase are used to relieve the symptoms of hay fever and to prevent reg rowth of nasal polyps following surgical removal. Do not expect immediate relief from beclomethasone, and do not take higher doses in an attempt to make it work It is not intended for rapid relief, but it will help control symptoms when taken routinely. Beclomethasone is prescribed in an oral inhalant or a nasal spray form.

Use this medication only as preventive therapy, and take only the dose prescribed. Although some people begin to notice improvement within a day or two, it may take 1 or 2 weeks for the full benefits to appear. If there’s no improvement after 3 weeks, let your doctor know. During the first week, you’ll probably take the usual number of tablets. After that, you’ll be instructed to slowly reduce the number of tablets, replacing them with the inhalant. Be sure to take the drug regularly, even if you have no symptoms. Get answers from our experts and community members

Beclomethasone dipropionate is a corticosteroid that produces anti-inflammatory activity.
In rare instances, hypersensitivity reactions (such as hives, rash and bronchospasm) have been reported following the oral and intranasal inhalation of beclomethasone dipropionate. Inflammation occurs in both large and small airways.
Corticosteroids have multiple anti-inflammatory effects, inhibiting both inflammatory cells and release of inflammatory mediators. Inhaled beclomethasone dipropionate probably acts topically at the site of deposition in the bronchial tree after inhalation

Beclomethasone is used to relieve allergic and non-allergic nasal symptoms (sneezing, itching, runny/stuffy nose) It may also be used to prevent the return of growths in the nose (nasal polyps) after removal by surgery. Beclomethasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages. Read the Patient Information Leaflet provided by your pharmacist before you start using beclomethasone and each time you get a refill. If you have any questions, consult your doctor or pharmacist. Shake the bottle gently before each use.
Remove the safety clip and plastic cap. Follow the instructions on how to properly prime the spray if you are using a bottle for the first time or if you have not used it for 7 days. A fine spray means that the pump is primed properly.

Spray Beclomethasone into the nose, usually twice daily or as directed by your doctor.
Gently blow your nose before using this drug. Close one nostril with a finger and lean your head slightly forward. Insert the spray tip into the other nostril. Spray the medication into the open nostril. Breathe in gently through the nostril, then gently breathe out through your mouth. If more sprays are prescribed, repeat in the same nostril.
Then repeat for the other nostril if so directed. Avoid blowing your nose for 15 minutes after using the medication. Avoid spraying the medication into your eyes or onto the middle of the inside of your nose (nasal septum). Replace the plastic cap and safety clip after each use. Use this medication regularly in order to get the most benefit from it. This medication works best if used at evenly spaced intervals. To help you remember, use it at the same times each day.

www.healasthma.com